Intrinsic unresponsiveness of Mertk-/- B cells to chronic graft-versus-host disease is associated with unmodulated CD1d expression

Journal of Autoimmunity

Volumn 39, Issue 4, 2012, Pages 412-419

  Shao, Wen Hai ^a   Zhen, Yuxuan ^a   Finkelman, Fred D ^b,d   Eisenberg, Robert A ^c   Cohen, Philip L ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

CD1d; CGVH; GC; MHC II; MZ B cell

Indexed keywords

AUTOANTIBODY; CD1D ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MER RECEPTOR TYROSINE KINASE; PROTEIN TYROSINE KINASE; TYROSINE; UNCLASSIFIED DRUG;

ALLOTYPE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CALCIUM MOBILIZATION; CHRONIC GRAFT VERSUS HOST DISEASE; CROSS LINKING; DOWN REGULATION; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1D; AUTOANTIBODIES; B-LYMPHOCYTES; CALCIUM; CHRONIC DISEASE; GENE EXPRESSION; GERMINAL CENTER; GRAFT VS HOST DISEASE; HUMANS; IMMUNOGLOBULIN ALLOTYPES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SPLEEN;

EID: 84869868380     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.07.001     Document Type: Article

References (33)

1. Vinuesa C.G., Sanz I., Cook M.C. Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol 2009, 9:845-857.
2. Duan B., Niu H., Xu Z., Sharpe A.H., Croker B.P., Sobel E.S., et al. Intrafollicular location of marginal zone/CD1d(hi) B cells is associated with autoimmune pathology in a mouse model of lupus. Lab Invest 2008, 88:1008-1020.
3. Wither J.E., Loh C., Lajoie G., Heinrichs S., Cai Y.C., Bonventi G., et al. Colocalization of expansion of the splenic marginal zone population with abnormal B cell activation and autoantibody production in B6 mice with an introgressed New Zealand black chromosome 13 interval. J Immunol 2005, 175:4309-4319.
4. Duan B., Croker B.P., Morel L. Lupus resistance is associated with marginal zone abnormalities in an NZM murine model. Lab Invest 2007, 87:14-28.
5. Wermeling F., Lind S.M., Jordo E.D., Cardell S.L., Karlsson M.C. Invariant NKT cells limit activation of autoreactive CD1d-positive B cells. J Exp Med 2010, 207:943-952.
6. Cohen P.L., Caricchio R., Abraham V., Camenisch T.D., Jennette J.C., Roubey R.A., et al. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 2002, 196:135-140.
7. Lu Q., Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 2001, 293:306-311.
8. Lemke G., Rothlin C.V. Immunobiology of the TAM receptors. Nat Rev Immunol 2008, 8:327-336.
9. Shao W.H., Zhen Y., Eisenberg R.A., Cohen P.L. The mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin Immunol 2009, 133:138-144.
10. Rothlin C.V., Ghosh S., Zuniga E.I., Oldstone M.B., Lemke G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 2007, 131:1124-1136.
11. Williams J.C., Wagner N.J., Earp H.S., Vilen B.J., Matsushima G.K. Increased hematopoietic cells in the mertk-/- mouse peritoneal cavity: a result of augmented migration. J Immunol 2010, 184:6637-6648.
12. Wallet M.A., Flores R.R., Wang Y., Yi Z., Kroger C.J., Mathews C.E., et al. MerTK regulates thymic selection of autoreactive T cells. Proc Natl Acad Sci U S A 2009, 106:4810-4815.
13. Sen P., Wallet M.A., Yi Z., Huang Y., Henderson M., Mathews C.E., et al. Apoptotic cells induce mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 2007, 109:653-660.
14. Shao W.H., Eisenberg R.A., Cohen P.L. The mer receptor tyrosine kinase is required for the loss of B cell tolerance in the chronic graft-versus-host disease model of systemic lupus erythematosus. J Immunol 2008, 180:7728-7735.
15. Shao W.H., Kuan A.P., Wang C., Abraham V., Waldman M.A., Vogelgesang A., et al. Disrupted mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. J Autoimmun 2010, 35:368-374.
16. Qian Y., Wang H., Clarke S.H. Impaired clearance of apoptotic cells induces the activation of autoreactive anti-Sm marginal zone and B-1 B cells. J Immunol 2004, 172:625-635.
17. Morris S.C., Cheek R.L., Cohen P.L., Eisenberg R.A. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med 1990, 171:503-517.
18. Finkelman F.D., Morris S.C. Development of an assay to measure in vivo cytokine production in the mouse. Int Immunol 1999, 11:1811-1818.
19. Choudhury A., Maldonado M.A., Cohen P.L., Eisenberg R.A. The role of host CD4 T cells in the pathogenesis of the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 2005, 174:7600-7609.
20. Cohen P.L., Maldonado M.A. Animal models for SLE. Curr Protoc Immunol 2003, [Chapter 15]: Unit 15 20.
21. Caberoy N.B., Maiguel D., Kim Y., Li W. Identification of tubby and tubby-like protein 1 as eat-me signals by phage display. Exp Cell Res 2010, 316:245-257.
22. Angelillo-Scherrer A., De Frutos P., Aparicio C., Melis E., Savi P., Lupu F., et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med 2001, 7:215-221.
23. Burnier L., Saller F., Kadi L., Brisset A.C., Sugamele R., Baudino L., et al. Gas6 deficiency in recipient mice of allogeneic transplantation alleviates hepatic graft-versus-host disease. Blood 2010, 115:3390-3397.
24. Cambier J.C., Newell M.K., Justement L.B., McGuire J.C., Leach K.L., Chen Z.Z. Ia binding ligands and cAMP stimulate nuclear translocation of PKC in B lymphocytes. Nature 1987, 327:629-632.
25. Nashar T.O., Drake J.R. The pathway of antigen uptake and processing dictates MHC class II-mediated B cell survival and activation. J Immunol 2005, 174:1306-1316.
26. Grimaldi C.M., Michael D.J., Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 2001, 167:1886-1890.
27. Wither J.E., Roy V., Brennan L.A. Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZB×NZW) F(1) mice. Clin Immunol 2000, 94:51-63.
28. Lang G.A., Devera T.S., Lang M.L. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. Blood 2008, 111:2158-2162.
29. Eisenberg R.A. The chronic graft-versus-host model of systemic autoimmunity. Curr Dir Autoimmun 2003, 6:228-244.
30. Todt J.C., Hu B., Curtis J.L. The scavenger receptor SR-A I/II (CD204) signals via the receptor tyrosine kinase Mertk during apoptotic cell uptake by murine macrophages. J Leukoc Biol 2008, 84:510-518.
31. Oliver A.M., Martin F., Gartland G.L., Carter R.H., Kearney J.F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997, 27:2366-2374.
32. Oliver A.M., Martin F., Kearney J.F. IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999, 162:7198-7207.
33. Schuster H., Martin T., Marcellin L., Garaud J.C., Pasquali J.L., Korganow A.S. Expansion of marginal zone B cells is not sufficient for the development of renal disease in NZB×NZW F1 mice. Lupus 2002, 11:277-286.